These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 21609268)

  • 1. Antifungal prophylaxis in solid organ transplant recipients.
    Brizendine KD; Vishin S; Baddley JW
    Expert Rev Anti Infect Ther; 2011 May; 9(5):571-81. PubMed ID: 21609268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive fungal infections in liver transplantation.
    Liu X; Ling Z; Li L; Ruan B
    Int J Infect Dis; 2011 May; 15(5):e298-304. PubMed ID: 21345708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic antifungal agents used after lung transplantation.
    Marino E; Gallagher JC
    Ann Pharmacother; 2010 Mar; 44(3):546-56. PubMed ID: 20179260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
    McCoy D; Depestel DD; Carver PL
    Pharmacotherapy; 2009 Nov; 29(11):1306-25. PubMed ID: 19857148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and treatment of fungal infections in solid-organ transplant recipients].
    Muñoz P; Bouza E
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304
    [No Abstract]   [Full Text] [Related]  

  • 7. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.
    Singh N
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S200-6. PubMed ID: 15546118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
    Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
    Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients.
    Grossi PA; Gasperina DD; Barchiesi F; Biancofiore G; Carafiello G; De Gasperi A; Sganga G; Menichetti F; Montagna MT; Pea F; Venditti M; Viale P; Viscoli C; Nanni Costa A
    Transplant Proc; 2011; 43(6):2463-71. PubMed ID: 21839295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
    Playford EG; Webster AC; Sorell TC; Craig JC
    Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive fungal infections and antifungal therapies in solid organ transplant recipients.
    Gabardi S; Kubiak DW; Chandraker AK; Tullius SG
    Transpl Int; 2007 Dec; 20(12):993-1015. PubMed ID: 17617181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
    Michallet M; Ito JI
    J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
    Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
    Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal prophylaxis in lung transplantation.
    Avery RK
    Semin Respir Crit Care Med; 2011 Dec; 32(6):717-26. PubMed ID: 22167399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
    Strasfeld L; Weinstock DM
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal prophylaxis in liver transplant recipients.
    Eschenauer GA; Lam SW; Carver PL
    Liver Transpl; 2009 Aug; 15(8):842-58. PubMed ID: 19642130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
    López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM
    Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
    Koo S; Kubiak DW; Issa NC; Dietzek A; Boukedes S; Camp PC; Goldberg HJ; Baden LR; Fuhlbrigge AL; Marty FM
    Transplantation; 2012 Aug; 94(3):281-6. PubMed ID: 22790447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
    Solé A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.